Dr. Scott Gottlieb, who has served as FDA Commissioner since May 2017, has announced that he will be resigning from the agency. Dr. Gottlieb has previously voiced support for wider access to biosimilars.
Dr. Scott Gottlieb, who has served as FDA Commissioner since May 2017, has announced that he will be resigning from the agency. Dr. Gottlieb has previously voiced support for wider access to biosimilars.
Comments are closed.